Which has higher earnings and valuation, KRMD or SGP?

Spyglass Pharma has lower revenue, but higher earnings than KORU Medical Systems. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio KORU Medical Systems $41.13M 4.44 -$2.64M -$0.05 N/A Spyglass Pharma N/A N/A N/A N/A N/A

KORU Medical Systems (KRMD) Competitors

$3.98 -0.02 (-0.50%)

Closing price 04:00 PM Eastern

Extended Trading

$3.98 0.00 (-0.13%)

As of 04:10 PM Eastern

Compare

KRMD vs. CBLL, BVS, BWAY, SIBN, and SGP

Should you buy KORU Medical Systems stock or one of its competitors? MarketBeat compares KORU Medical Systems with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with KORU Medical Systems include CeriBell (CBLL), Bioventus (BVS), Brainsway (BWAY), SiBone (SIBN), and Spyglass Pharma (SGP). These companies are all part of the "medical equipment" industry.

How does KORU Medical Systems compare to CeriBell?

CeriBell (NASDAQ:CBLL) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, risk, earnings, dividends, valuation, profitability and analyst recommendations.

KORU Medical Systems has lower revenue, but higher earnings than CeriBell. KORU Medical Systems is trading at a lower price-to-earnings ratio than CeriBell, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CeriBell	$89.06M	7.83	-$53.41M	-$1.63	N/A
KORU Medical Systems	$41.13M	4.44	-$2.64M	-$0.05	N/A

In the previous week, CeriBell had 3 more articles in the media than KORU Medical Systems. MarketBeat recorded 4 mentions for CeriBell and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.89 beat CeriBell's score of 0.87 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
CeriBell	Positive
KORU Medical Systems	Very Positive

KORU Medical Systems has a net margin of -5.27% compared to CeriBell's net margin of -63.51%. KORU Medical Systems' return on equity of -13.61% beat CeriBell's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CeriBell	-63.51%	-38.19%	-30.92%
KORU Medical Systems	-5.27%	-13.61%	-8.33%

CeriBell has a beta of 0.84, meaning that its stock price is 16% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market.

CeriBell presently has a consensus target price of $22.20, indicating a potential upside of 20.78%. KORU Medical Systems has a consensus target price of $7.25, indicating a potential upside of 82.16%. Given KORU Medical Systems' higher possible upside, analysts clearly believe KORU Medical Systems is more favorable than CeriBell.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CeriBell	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.83
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

58.6% of KORU Medical Systems shares are held by institutional investors. 20.1% of CeriBell shares are held by company insiders. Comparatively, 18.5% of KORU Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

CeriBell and KORU Medical Systems tied by winning 8 of the 16 factors compared between the two stocks.

How does KORU Medical Systems compare to Bioventus?

KORU Medical Systems (NASDAQ:KRMD) and Bioventus (NASDAQ:BVS) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, valuation, analyst recommendations, media sentiment, earnings, risk and institutional ownership.

In the previous week, Bioventus had 3 more articles in the media than KORU Medical Systems. MarketBeat recorded 4 mentions for Bioventus and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.89 beat Bioventus' score of 1.00 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Overall Sentiment
KORU Medical Systems	Very Positive
Bioventus	Positive

KORU Medical Systems has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market. Comparatively, Bioventus has a beta of 0.67, indicating that its share price is 33% less volatile than the broader market.

Bioventus has a net margin of 4.94% compared to KORU Medical Systems' net margin of -5.27%. Bioventus' return on equity of 29.97% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-5.27%	-13.61%	-8.33%
Bioventus	4.94%	29.97%	9.52%

Bioventus has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Bioventus, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	4.44	-$2.64M	-$0.05	N/A
Bioventus	$568.09M	1.33	$22.73M	$0.41	22.07

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 62.9% of Bioventus shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by company insiders. Comparatively, 33.0% of Bioventus shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

KORU Medical Systems presently has a consensus target price of $7.25, suggesting a potential upside of 82.16%. Bioventus has a consensus target price of $14.00, suggesting a potential upside of 54.70%. Given KORU Medical Systems' higher probable upside, equities analysts clearly believe KORU Medical Systems is more favorable than Bioventus.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Bioventus	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	1 Strong Buy rating(s)	3.00

Summary

Bioventus beats KORU Medical Systems on 13 of the 17 factors compared between the two stocks.

How does KORU Medical Systems compare to Brainsway?

KORU Medical Systems (NASDAQ:KRMD) and Brainsway (NASDAQ:BWAY) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, profitability, media sentiment, institutional ownership and earnings.

KORU Medical Systems currently has a consensus target price of $7.25, indicating a potential upside of 82.16%. Brainsway has a consensus target price of $16.00, indicating a potential upside of 13.07%. Given KORU Medical Systems' higher possible upside, equities analysts clearly believe KORU Medical Systems is more favorable than Brainsway.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Brainsway	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Brainsway has higher revenue and earnings than KORU Medical Systems. KORU Medical Systems is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	4.44	-$2.64M	-$0.05	N/A
Brainsway	$52.22M	10.86	$7.57M	$0.35	40.43

In the previous week, Brainsway had 2 more articles in the media than KORU Medical Systems. MarketBeat recorded 3 mentions for Brainsway and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.89 beat Brainsway's score of 0.62 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Overall Sentiment
KORU Medical Systems	Very Positive
Brainsway	Positive

58.6% of KORU Medical Systems shares are owned by institutional investors. Comparatively, 30.1% of Brainsway shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by insiders. Comparatively, 19.0% of Brainsway shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Brainsway has a net margin of 15.68% compared to KORU Medical Systems' net margin of -5.27%. Brainsway's return on equity of 12.28% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-5.27%	-13.61%	-8.33%
Brainsway	15.68%	12.28%	7.75%

KORU Medical Systems has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market. Comparatively, Brainsway has a beta of 1.2, suggesting that its stock price is 20% more volatile than the broader market.

Summary

Brainsway beats KORU Medical Systems on 12 of the 16 factors compared between the two stocks.

How does KORU Medical Systems compare to SiBone?

SiBone (NASDAQ:SIBN) and KORU Medical Systems (NASDAQ:KRMD) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, media sentiment, earnings, risk, valuation, institutional ownership and profitability.

SiBone has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market. Comparatively, KORU Medical Systems has a beta of 0.43, suggesting that its stock price is 57% less volatile than the broader market.

98.1% of SiBone shares are held by institutional investors. Comparatively, 58.6% of KORU Medical Systems shares are held by institutional investors. 3.9% of SiBone shares are held by insiders. Comparatively, 18.5% of KORU Medical Systems shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

KORU Medical Systems has lower revenue, but higher earnings than SiBone. KORU Medical Systems is trading at a lower price-to-earnings ratio than SiBone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SiBone	$200.93M	3.39	-$18.90M	-$0.39	N/A
KORU Medical Systems	$41.13M	4.44	-$2.64M	-$0.05	N/A

In the previous week, SiBone had 4 more articles in the media than KORU Medical Systems. MarketBeat recorded 5 mentions for SiBone and 1 mentions for KORU Medical Systems. KORU Medical Systems' average media sentiment score of 1.89 beat SiBone's score of 0.45 indicating that KORU Medical Systems is being referred to more favorably in the news media.

Company	Overall Sentiment
SiBone	Neutral
KORU Medical Systems	Very Positive

SiBone currently has a consensus price target of $23.00, suggesting a potential upside of 49.64%. KORU Medical Systems has a consensus price target of $7.25, suggesting a potential upside of 82.16%. Given KORU Medical Systems' higher possible upside, analysts clearly believe KORU Medical Systems is more favorable than SiBone.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SiBone	1 Sell rating(s)	0 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.71
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60

KORU Medical Systems has a net margin of -5.27% compared to SiBone's net margin of -8.10%. SiBone's return on equity of -9.56% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SiBone	-8.10%	-9.56%	-7.06%
KORU Medical Systems	-5.27%	-13.61%	-8.33%

Summary

SiBone beats KORU Medical Systems on 9 of the 16 factors compared between the two stocks.

How does KORU Medical Systems compare to Spyglass Pharma?

KORU Medical Systems (NASDAQ:KRMD) and Spyglass Pharma (NASDAQ:SGP) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their analyst recommendations, risk, profitability, valuation, dividends, institutional ownership, earnings and media sentiment.

KORU Medical Systems presently has a consensus price target of $7.25, indicating a potential upside of 82.16%. Spyglass Pharma has a consensus price target of $45.00, indicating a potential upside of 150.42%. Given Spyglass Pharma's stronger consensus rating and higher possible upside, analysts plainly believe Spyglass Pharma is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Spyglass Pharma	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

Spyglass Pharma has lower revenue, but higher earnings than KORU Medical Systems.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	4.44	-$2.64M	-$0.05	N/A
Spyglass Pharma	N/A	N/A	N/A	N/A	N/A

In the previous week, KORU Medical Systems and KORU Medical Systems both had 1 articles in the media. KORU Medical Systems' average media sentiment score of 1.89 beat Spyglass Pharma's score of 1.87 indicating that KORU Medical Systems is being referred to more favorably in the media.

Company	Overall Sentiment
KORU Medical Systems	Very Positive
Spyglass Pharma	Very Positive

58.6% of KORU Medical Systems shares are owned by institutional investors. 18.5% of KORU Medical Systems shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Spyglass Pharma has a net margin of 0.00% compared to KORU Medical Systems' net margin of -5.27%. Spyglass Pharma's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-5.27%	-13.61%	-8.33%
Spyglass Pharma	N/A	N/A	N/A

Summary

Spyglass Pharma beats KORU Medical Systems on 6 of the 10 factors compared between the two stocks.

Get KORU Medical Systems News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding KRMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

KRMD vs. The Competition

Export

Metric	KORU Medical Systems	MEDICAL INFO SYS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$182.80M	$1.53B	$6.43B	$11.71B
Dividend Yield	N/A	N/A	2.67%	5.55%
P/E Ratio	-79.60	77.43	24.46	23.62
Price / Sales	4.44	7.16	500.50	105.27
Price / Cash	N/A	22.77	42.36	56.09
Price / Book	10.76	4.84	10.43	6.70
Net Income	-$2.64M	-$54.76M	$3.56B	$337.26M
7 Day Performance	1.14%	-2.90%	-1.39%	-1.41%
1 Month Performance	-5.24%	1.34%	0.86%	1.15%
1 Year Performance	24.38%	-11.73%	19.42%	22.61%

KORU Medical Systems Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
KRMD KORU Medical Systems	4.1712 of 5 stars	$3.98 -0.5%	$7.25 +82.2%	+32.5%	$182.80M	$41.13M	N/A	80	Positive News
CBLL CeriBell	2.476 of 5 stars	$17.50 -0.6%	$22.20 +26.9%	+3.9%	$668.17M	$89.06M	N/A	N/A	Insider Trade
BVS Bioventus	4.3284 of 5 stars	$8.11 +2.3%	$14.00 +72.6%	N/A	$662.43M	$568.09M	19.78	1,200	News Coverage
BWAY Brainsway	2.9479 of 5 stars	$14.56 -5.7%	$16.00 +9.9%	+162.1%	$618.38M	$52.22M	41.60	120	News Coverage Gap Down
SIBN SiBone	2.323 of 5 stars	$14.01 +1.0%	$23.00 +64.2%	-17.7%	$615.12M	$200.93M	N/A	350	Gap Up

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:KRMD) was last updated on 6/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

KORU Medical Systems (KRMD) Competitors

KRMD vs. CBLL, BVS, BWAY, SIBN, and SGP

How does KORU Medical Systems compare to CeriBell?

Summary

How does KORU Medical Systems compare to Bioventus?

Summary

How does KORU Medical Systems compare to Brainsway?

Summary

How does KORU Medical Systems compare to SiBone?

Summary

How does KORU Medical Systems compare to Spyglass Pharma?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KRMD vs. The Competition

KORU Medical Systems Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

KORU Medical Systems (KRMD) Competitors

KRMD vs. CBLL, BVS, BWAY, SIBN, and SGP

How does KORU Medical Systems compare to CeriBell?

Which has higher earnings & valuation, CBLL or KRMD?

Does the media favor CBLL or KRMD?

Is CBLL or KRMD more profitable?

Which has more volatility and risk, CBLL or KRMD?

Do analysts recommend CBLL or KRMD?

Do insiders & institutionals have more ownership in CBLL or KRMD?

Summary

How does KORU Medical Systems compare to Bioventus?

Does the media prefer KRMD or BVS?

Which has more risk & volatility, KRMD or BVS?

Is KRMD or BVS more profitable?

Which has better earnings and valuation, KRMD or BVS?

Do institutionals and insiders have more ownership in KRMD or BVS?

Do analysts recommend KRMD or BVS?

Summary

How does KORU Medical Systems compare to Brainsway?

Do analysts prefer KRMD or BWAY?

Which has better valuation & earnings, KRMD or BWAY?

Does the media refer more to KRMD or BWAY?

Do institutionals & insiders have more ownership in KRMD or BWAY?

Is KRMD or BWAY more profitable?

Which has more volatility and risk, KRMD or BWAY?

Summary

How does KORU Medical Systems compare to SiBone?

Which has more volatility and risk, SIBN or KRMD?

Do institutionals and insiders hold more shares of SIBN or KRMD?

Which has preferable valuation & earnings, SIBN or KRMD?

Does the media prefer SIBN or KRMD?

Do analysts recommend SIBN or KRMD?

Is SIBN or KRMD more profitable?

Summary

How does KORU Medical Systems compare to Spyglass Pharma?

Do analysts rate KRMD or SGP?

Which has higher earnings and valuation, KRMD or SGP?

Does the media prefer KRMD or SGP?

Do institutionals and insiders have more ownership in KRMD or SGP?

Is KRMD or SGP more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

KRMD vs. The Competition

KORU Medical Systems Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools